The very high rate of early recurrences following upfront pancreatectomy for pancreatic adenocarcinoma is one of the main reasons for the ongoing shift towards a chemotherapy-first policy.
1 However, the extent to which neoadjuvant therapies prolong the recurrence-free interval following pancreatectomy is ill defined. …